MTOR and gastric cancer: These findings are in keeping with studies implicating mTOR signaling in human gastric cancers (reviewed in [41]), mouse models of gastric cancer [8, 28], and a recent report identifying activating mutations in the upstream effector PIK3CA in a subset of human gastric cancers [6].